Andere Sprachen ESSA Pharma Inc.

Aktien

A2JKQ4

CA29668H7085

EPIX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 07.05.2024			% 5 Tage	% 1. Jan.
6,82 ^USD	-2,29 %		+6,07 %	+3,33 %

06.03.	Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call
06.03.	Norwegens Wohlstandsfonds drängt auf mehr Frauen in den Vorständen von Schwellenländerunternehmen	RE

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	09.04.
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08.03.
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08.03.
Norway's wealth fund pushes for more women on emerging market company boards	06.03.
ESSA Pharma : Passive Foreign Investment Company Statement	28.02.
ESSA Pharma: Fiscal Q1 Earnings Snapshot	13.02.
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	13.02.
ESSA Pharma Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	13.02.
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06.02.
ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	26.01.
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	25.01.
ESSA Pharma: Fiscal Q4 Earnings Snapshot	12.12.
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023	12.12.
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	12.12.
Essa Pharma Insider Bought Shares Worth $133,274, According to a Recent SEC Filing	24.11.
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference	21.11.
Essa Pharma Insider Bought Shares Worth $419,661, According to a Recent SEC Filing	16.11.
ESSA Pharma to Present at the Jefferies London Healthcare Conference	08.11.
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	06.11.
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	06.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ESSA Pharma Inc.

Aktien

A2JKQ4

CA29668H7085

EPIX

Andere Sprachen

Filter